Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Lymphoma

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 60 articles: HTML format

Single Articles

June 2009
1. DUGAN MJ , Maziarz RT, Bensinger WI, Nademanee A, et al
   Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles    Abstract available
   
   
   May 2009
2. AMBINDER RF
   The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. HUANG Q , Popplewell L, Lu Y, Slovak ML, et al
   Late onset of EBV-driven PTLD/Burkitt lymphoma/leukemia in a patient 10 years after allogeneic stem cell transplant for AML.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles   
   
   
   
4. SCHROEDER T , Zohren F, Saure C, Kobbe G, et al
   Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles   
   
   
   March 2009
5. BUHMANN R , Simoes B, Stanglmaier M, Yang T, et al
   Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.
   Bone Marrow Transplant. 2009;43:383-97.
   PubMed     Related articles    Abstract available
   
   
   February 2009
6. SOHN BS , Park I, Kim EK, Yoon DH, et al
   Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles    Abstract available
   
   
   January 2009
7. HEIZMANN M , O'Meara AC, Moosmann PR, Heijnen IA, et al
   Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles    Abstract available
   
   
   
8. ESCALON MP , Stefanovic A, Venkatraman A, Pereira D, et al
   Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles    Abstract available
   
   
   
9. HOPPE BS , Moskowitz CH, Zhang Z, Maragulia JC, et al
   The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.
   Bone Marrow Transplant. 2009.
   PubMed     Related articles    Abstract available
   
   
   
10. MCCANN S , Schwenkglenks M, Bacon P, Einsele H, et al
    The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    Bone Marrow Transplant. 2009;43:141-7.
    PubMed     Related articles    Abstract available
    
    
    November 2008
11. HICKS LK , Woods A, Buckstein R, Mangel J, et al
    Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    October 2008
12. MAGNI M , Di Nicola M, Carlo-Stella C, Matteucci P, et al
    High-dose sequential chemotherapy and in vivo Rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles   
    
    
    
13. GUTIERREZ A , Caballero MD, Perez-Manga G, Rodriguez J, et al
    Hematopoietic SCT for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
14. HALLACK NETO AE , Dulley FL, Coelho Siqueira SA, Pracchia LF, et al
    Prognostic impact of diffuse large B-cell lymphoma subgroups in patients undergoing autologous SCT.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
15. CLAVIEZ A , Sureda A, Schmitz N
    Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008;42 Suppl 2:S16-24.
    PubMed     Related articles    Abstract available
    
    
    
16. FLESCH B , Miller J, Repp R, Ott S, et al
    Successful autologous hematopoietic progenitor cell transplantation in a patient with an isoantibody against CD36 (glycoprotein IV, Naka).
    Bone Marrow Transplant. 2008;42:489-91.
    PubMed     Related articles   
    
    
    
17. COSTA LJ , Rodriguez V, Porrata LF, Lacy MQ, et al
    Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
    Bone Marrow Transplant. 2008;42:497-8.
    PubMed     Related articles   
    
    
    
18. SUCAK GT , Yegin ZA, Ozkurt ZN, Aki SZ, et al
    The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
    Bone Marrow Transplant. 2008;42:461-7.
    PubMed     Related articles    Abstract available
    
    
    September 2008
19. HO J , Yang L, Banihashemi B, Martin L, et al
    Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
20. BACHANOVA V , Brunstein CG, Burns LJ, Miller JS, et al
    Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
21. YUSUF RZ , Dey B, Yeap BY, McAfee S, et al
    Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
22. COPELAN E , Pohlman B, Rybicki L, Kalaycio M, et al
    A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
23. KOLSTAD A , Tjonnfjord G, Jonsson V
    High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT.
    Bone Marrow Transplant. 2008;42:427-8.
    PubMed     Related articles   
    
    
    August 2008
24. BUSER A , Stern M, Arber C, Medinger M, et al
    Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
25. RAMADAN KM , Connors JM, Al-Tourah AJ, Song KW, et al
    Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
26. DAMON L , Damon LE, Gaensler K, Kaplan L, et al
    Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008.
    PubMed     Related articles    Abstract available
    
    
    
27. AKHTAR S , Abdelsalam M, El Weshi A, Al Husseini H, et al
    High-dose chemotherapy and autologous stem cell transplantation for Hodgkin's lymphoma in the kingdom of Saudi Arabia: King Faisal specialist hospital and research center experience.
    Bone Marrow Transplant. 2008;42 Suppl 1:S37-S40.
    PubMed     Related articles    Abstract available
    
    
    
28. MALONEY D
    Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
    Bone Marrow Transplant. 2008;42 Suppl 1:S35-S36.
    PubMed     Related articles    Abstract available
    
    
    
29. BAZARBACHI A , Hatoum H, Mugharbel A, Otrock Z, et al
    Hematopoietic stem cell transplantation in Lebanon: first comprehensive report.
    Bone Marrow Transplant. 2008;42 Suppl 1:S96-S102.
    PubMed     Related articles    Abstract available
    
    
    
30. FRONKOVA E , Muzikova K, Mejstrikova E, Kovac M, et al
    B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL.
    Bone Marrow Transplant. 2008;42:187-96.
    PubMed     Related articles    Abstract available
    
    
    July 2008
31. MURALI S , Winton E, Waller EK, Heffner LT, et al
    Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. SCHLEMMER F , Lagrange-Xelot M, Lacroix C, de La Tour R, et al
    Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles   
    
    
    June 2008
33. SAIRAFI D , Uzunel M, Remberger M, Ringden O, et al
    No impact of NOD2/CARD15 on outcome after SCT.
    Bone Marrow Transplant. 2008;41:961-4.
    PubMed     Related articles    Abstract available
    
    
    
34. CHUNDURI S , Dobogai LC, Peace D, Saunthararajah Y, et al
    Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
    Bone Marrow Transplant. 2008;41:935-40.
    PubMed     Related articles    Abstract available
    
    
    May 2008
35. LIM SH , Zhang Y, Burris C, Townsend M, et al
    Successful salvage with unrelated umbilical cord blood transplant for Hodgkin's disease relapsed following autologous stem cell transplant.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles   
    
    
    
36. KORNBLIT B , Masmas T, Madsen HO, Ryder LP, et al
    Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants.
    Bone Marrow Transplant. 2008;41:851-9.
    PubMed     Related articles    Abstract available
    
    
    
37. GRULLICH C , Bertz H, Spyridonidis A, Muller CI, et al
    A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
    Bone Marrow Transplant. 2008;41:845-50.
    PubMed     Related articles    Abstract available
    
    
    April 2008
38. JOHNSTON PB , Wiseman GA, Micallef IN
    Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. NYMAN H , Jantunen E, Juvonen E, Elonen E, et al
    Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
40. YONEKURA K , Utsunomiya A, Takatsuka Y, Takeuchi S, et al
    Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. SESHADRI T , Pintilie M, Keating A, Crump M, et al
    The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
42. THOMSON KJ , Peggs KS, Smith P, Cavet J, et al
    Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. COSTA LJ , Micallef IN, Inwards DJ, Johnston PB, et al
    Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. DUARTE RF , Schmitz N, Servitje O, Sureda A, et al
    Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
    Bone Marrow Transplant. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
45. BRADLEY MB , Cairo MS
    Stem cell transplantation for pediatric lymphoma: past, present and future.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. YAMAMOTO R , Takaori-Kondo A, Kanda J, Imada K, et al
    Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
47. BENEKLI M , Smiley SL, Younis T, Czuczman MS, et al
    Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
48. BENSON DM JR , Smith MK, Krugh D, Devine SM, et al
    Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles   
    
    
    
49. SHIMONI A , Zwas ST, Oksman Y, Hardan I, et al
    Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. CALANDRA G , McCarty J, McGuirk J, Tricot G, et al
    AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
51. ELMAAGACLI AH , Koldehoff M, Steckel NK, Trenschel R, et al
    Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation.
    Bone Marrow Transplant. 2007;40:659-64.
    PubMed     Related articles    Abstract available
    
    
    
52. NATH CE , Shaw PJ, Trotman J, Zeng L, et al
    Pharmacokinetics of melphalan in myeloma patients undergoing an autograft.
    Bone Marrow Transplant. 2007;40:707-8.
    PubMed     Related articles   
    
    
    
53. KAMBLE RT , Bollard C, Demmler G, LaSala PR, et al
    Human metapneumovirus infection in a hematopoietic transplant recipient.
    Bone Marrow Transplant. 2007;40:699-700.
    PubMed     Related articles   
    
    
    September 2007
54. ARBER C , Buser A, Heim D, Weisser M, et al
    Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment.
    Bone Marrow Transplant. 2007;40:597-8.
    PubMed     Related articles   
    
    
    July 2007
55. BARKHOLT L , Remberger M, Bodegard H, Ringden O, et al
    Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. MACLEAN PS , Parker AN, McQuaker IG, Clark AD, et al
    Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. PICCIRILLO N , De Matteis S, De Vita S, Laurenti L, et al
    Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. BOLWELL BJ , Pohlman B, Rybicki L, Sobecks R, et al
    Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
59. FEYLER S , Prince HM, Pearce R, Towlson K, et al
    The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. VAN DER VELDEN AM , Claessen AM, van Velzen-Blad H, Biesma DH, et al
    Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of gamma-interferon.
    Bone Marrow Transplant. 2007;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: